The single-nucleotide polymorphism (SNP), rs1042714 or glutamine 27 glutamic acid (Gln27Glu), in the adrenoceptor β2 surface (ADRB2) gene has previously been examined for association with obesity with inconclusive results. The objective of this study was to determine whether the ADRB2 rs1042714 SNP could influence obesity and obesity-related metabolic traits in a Taiwanese population.
Methods
The ADRB2 rs1042714 SNP and obesity-related metabolic traits including blood pressure, total cholesterol, triglyceride, fasting glucose, waist circumference, and body mass index (BMI) were examined in 967 individuals with general health examinations.
Results
Our data revealed that the ADRB2 rs1042714 SNP exhibited a significant association with obesity among the subjects (P = 0.021). Furthermore, the carriers of the GG genotype had a significantly higher BMI than those with the CC genotype (26.0 ± 5.6 vs 24.3 ± 3.8 kg/m2; P = 0.009) and those with the CG genotype (26.0 ± 5.6 vs 23.6 ± 3.3 kg/m2; P = 0.001). We also found a nominal association with systolic blood pressure (P = 0.058) and triglyceride (P = 0.055) levels in the ADRB2 rs1042714 SNP.
Conclusions
Our study indicates that the ADRB2 rs1042714 SNP may contribute to the risk of obesity and predict obesity-related metabolic traits such as BMI, triglyceride, and systolic blood pressure in Taiwanese subjects.
PhillipsCM.Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients. 2013; 5: 32–57.
6.
DayFR, LoosRJ.Developments in obesity genetics in the era of genome-wide association studies. J Nutrigenet Nutrigenomics. 2011; 4: 222–238.
7.
Hagström-ToftE, EnokssonS, MobergE, . beta-Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo. Am J Physiol. 1998; 275: E909–E916.
8.
EnokssonS, TalbotM, RifeF, . Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls. Diabetes. 2000; 49: 2149–2153.
9.
MasuoK.Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome. Int J Hypertens. 2010; 2010: 832821.
10.
MasuoK, LambertGW.Relationships of adrenoceptor polymorphisms with obesity. J Obes. 2011; 2011: 609485.
11.
UkkolaO, TremblayA, BouchardC.beta-2 Adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. Int J Obes Relat Metab Disord. 2001; 25: 1604–1608.
12.
GavinMC, Newton-ChehC, GazianoJM, . A common variant in the β2-adrenergic receptor and risk of sudden cardiac death. Heart Rhythm. 2011; 8: 704–710.
13.
LargeV, HellströmL, ReynisdottirS, . Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest. 1997; 100: 3005–3013.
14.
HellströmL, LargeV, ReynisdottirS, . The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med. 1999; 245: 253–259.
15.
UkkolaO, RankinenT, WeisnagelSJ, . Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism. 2000; 49: 1063–1070.
16.
MeirhaegheA, HelbecqueN, CottelD, . Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord. 2000; 24: 382–387.
17.
González SánchezJL, ProenzaAM, Martínez LarradMT, . The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. Clin Endocrinol (Oxf). 2003; 59: 476–481.
18.
PereiraAC, FlorianoMS, MotaGF, . beta2 Adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension. 2003; 42: 685–692.
19.
NakaI, HikamiK, NakayamaK, . A functional SNP upstream of the beta-2 adrenergic receptor gene (ADRB2) is associated with obesity in Oceanic populations [published online ahead of print]. Int J Obes (Lond). 2013; 37: 1204–1210.
20.
RosmondR, UkkolaO, ChagnonM, . Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med. 2000; 248: 239–244.
21.
KawamuraT, EgusaG, FujikawaR, . Gln27Glu variant of the beta2-adrenergic receptor gene is not associated with obesity and diabetes in Japanese-Americans. Metabolism. 2001; 50: 443–446.
22.
PereiraTV, Mingroni-NettoRC, YamadaY.ADRB2 and LEPR gene polymorphisms: synergistic effects on the risk of obesity in Japanese. Obesity (Silver Spring). 2011; 19: 1523–1527.
23.
KimSH, KimDJ, SeoIA, . Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism. 2002; 51: 833–837.
24.
GallettiF, IaconeR, RagoneE, . Lack of association between polymorphism in the beta2-adrenergic receptor gene, hypertension, and obesity in the Olivetti heart study. Am J Hypertens. 2004; 17 (8): 718–720.
25.
TafelJ, BranscheidI, SkwarnaB, . Variants in the human beta 1-, beta 2-, and beta 3-adrenergic receptor genes are not associated with morbid obesity in children and adolescents. Diabetes Obes Metab. 2004; 6: 452–455.
26.
GjesingAP, AndersenG, BurgdorfKS, . Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects. Diabetologia. 2007; 50: 563–568.
27.
ChouYC, TsaiCN, LeeYS, . Association of adrenergic receptor gene polymorphisms with adolescent obesity in Taiwan. Pediatr Int. 2012; 54: 111–116.
28.
ApalasamyYD, MingMF, RampalS, . Gender-dependent association of a β2-adrenergic gene variant with obesity parameters in Malaysian Malays. Asia Pac J Public Health. 2011Dec23. [Epub ahead of print].
29.
HsiaoTJ, HwangY, LiuCH, . Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese population. Genes Nutr. 2013; 8: 137–144.
30.
ChuNF.Prevalence of obesity in Taiwan. Obes Rev. 2005; 6: 271–274.
31.
WuLS, HsiehCH, PeiD, . Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPAR{gamma} and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant. 2009; 24: 3360–3366.
32.
WangCH, KeWS, LinE.Evaluation of the ENPP1 and PLIN single nucleotide polymorphisms with type 2 diabetes in a Taiwanese population: evidence for replication and gene-gene interaction. J Investig Med. 2012; 60: 1169–1173.
33.
HsiaoDJ, WuLS, HuangSY, . Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene. Pharmacogenet Genomics. 2009; 19: 730–733.
34.
Wittke-ThompsonJK, PluzhnikovA, CoxNJ.Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet. 2005; 76: 967–986.
35.
LafontanM, BerlanM.Fat cell adrenergic receptor and the control of white and brown fat cell function. J Lipid Res. 1993; 34: 1057–1091.
36.
van BaakMA.The peripheral sympathetic nervous system in human obesity. Obes Rev. 2001; 2: 3–14.
37.
BarbeP, MilletL, GalitzkyJ, . In situ assessment of the role of the beta1-, beta2- and beta3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol. 1996; 117: 907–913.
38.
Macho-AzcarateT, MartiA, CalabuigJ, . Basal far oxidation and after a peak oxygen consumption test in obese women with a beta2 adrenoceptor gene polymorphism. J Nutr Biochem. 2003; 14: 275–279.
BonoM, CasesA, CallsJ, . Effect of antihypertensive treatment on the increased beta 2-adrenoceptor density in patients with essential hypertension. Am J Hypertens. 1995; 8: 487–493.
41.
GuimarãesS, MouraD.Vascular adrenoceptors: an update. Pharmacol Rev. 2001; 53: 319–356.
42.
JockenJW, BlaakEE.Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol Behav. 2008; 94: 219–230.
43.
LinE, PeiD, HuangYJ, . Gene-gene interactions among genetic variants from obesity candidate genes for nonobese and obese populations in type 2 diabetes. Genet Test Mol Biomarkers. 2009; 13: 485–493.
44.
LiouYJ, BaiYM, LinE, . Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics. Pharmacogenomics J. 2012; 12: 54–61.
Velez EdwardsDR, NajAC, MondaK, . Gene-environment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women's Health Initiative SHARe Study. Hum Genet. 2013; 132: 323–336
